MariaCBellMDMPH, MBA(She/Her)

Obstetrics & Gynecology • Sioux Falls, SD

Gynecologic Oncology, Hospice & Palliative Medicine

Professor, Obstetrics & Gynecology, Sanford School of Medicine The University of South

Join to view full profile

Dr. Bell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bell's full profile

Already have an account?

Office
1500 W 22nd St
Ste 102
Sioux Falls, SD 57105
Phone+1 605-328-7700

Fax+1 605-328-7775

Summary

Dr. Maria Bell is a highly experienced provider in Obstetrics & Gynecology with subspecialties in Gynecologic Oncology and Hospice & Palliative Medicine, based in Fargo, ND. She completed her fellowship in Gynecologic Oncology at the University of Alabama Medical Center. Her experience extends into general obstetrics and gynecology, uterine fibroids, cervical cancer, and minimally invasive gynecologic surgery. Dr. Bell has several publications on related subjects, each cited multiple times, showcasing her continued contribution to the medical field. She's conducted numerous clinical trials and has received honors and awards, including the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation, and Fellowships from the American Congress of Obstetricians and Gynecologists and the American College of Surgeons.

Education & Training

University of Alabama Medical CenterFellowship, Gynecologic Oncology, 1992 - 1995
University of ChicagoResidency, Obstetrics and Gynecology, 1989 - 1992
Ascension Illinois/Saint Joseph (Chicago)Internship, Transitional Year, 1988 - 1989
University of South Dakota, Sanford School of MedicineClass of 1988

Certifications & Licensure

IA State Medical License 2010 - 2026
ND State Medical License 2011 - 2026
MN State Medical License 2008 - 2025
SD State Medical License Active through 2025
CO State Medical License 1999 - 2003
LA State Medical License 1995 - 2000
AL State Medical License 1992 - 1995
IL State Medical License 1991 - 1993
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
Active, not recruiting
Phase 2
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Start of enrollment: 2013 Apr 01
Completed
Phase 3
the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer Start of enrollment: 2019 Feb 11
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

77 citations
Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
Diane M. Maher, Maria C. Bell, Emmylu A. O'Donnell, Brij K. Gupta, Meena Jaggi
Molecular Carcinogenesis. 2011-01-01
19 citations
Teleoncology for gynecologic cancers
David I. Shalowitz, Allison G. Smith, Maria C. Bell, Randall K. Gibb
Gynecologic Oncology. 2015-10-01
151 citations
Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
Murali M. Yallapu, Diane M. Maher, Vasudha Sundram, Maria C. Bell, Meena Jaggi
Journal of Ovarian Research. 2010-04-29

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow
American College of Surgeons - ACS
Member